The New Ropanasuri Journal of Surgery
Volume 5

Number 1

Article 7

6-10-2020

A Solitary Bone Plasmacytoma In the Mandible: A Case Report
Erwin D. Yulian
Division of Oncology Surgery, Department of Surgery, Faculty of Medicine Universitas Indonesia, dr. Cipto
Mangunkusumo General Hospital, Jakarta, erwinjln@gmail.com

Andre S. Suryadi
Training Program of Surgery, Department of Surgery, Faculty of Medicine Universitas Indonesia, dr. Cipto
Mangunkusumo General Hospital, Jakarta, andresetiawan201054@gmail.com

Follow this and additional works at: https://scholarhub.ui.ac.id/nrjs
Part of the Surgery Commons

Recommended Citation
Yulian, Erwin D. and Suryadi, Andre S. (2020) "A Solitary Bone Plasmacytoma In the Mandible: A Case
Report," The New Ropanasuri Journal of Surgery: Vol. 5 : No. 1 , Article 7.
DOI: 10.7454/nrjs.v5i1.1062
Available at: https://scholarhub.ui.ac.id/nrjs/vol5/iss1/7

This Case Report is brought to you for free and open access by the Faculty of Medicine at UI Scholars Hub. It has
been accepted for inclusion in The New Ropanasuri Journal of Surgery by an authorized editor of UI Scholars Hub.

A Solitary Bone Plasmacytoma In the Mandible: A Case Report
Cover Page Footnote
SOLITARY BONE PLASMACYTOMA IN MANDIBLE BONE: A CASE REPORT Erwin Danil Yulian, Andre
Setiawan Division of Oncology Surgery, Departement of Surgery, Faculty of Medicine Universitas
Indonesia

This case report is available in The New Ropanasuri Journal of Surgery: https://scholarhub.ui.ac.id/nrjs/vol5/iss1/7

The New Ropanasuri Journal of Surgery 2020 Volume 5 No.1:25–27.

A Solitary Bone Plasmacytoma In the Mandible:
A Case Report
Erwin Danil Yulian,1 Andre Setiawan Suryadi.2
1. Division of Oncology Surgery, 2. Training Program in Surgery, Department of Surgery, Faculty of Medicine Universitas Indonesia, dr. Cipto Mangunkusumo General Hospital, Jakarta.
Corresponding author: erwinjln@gmail.com Received: 02/Jan/2020 Accepted: 27/May/2020 Published: 10/Jun/2020
Website: https://scholarhub.ui.ac.id/nrjs/ DOI:10.7454/nrjs.v5i1.1062

Abstract
Solitary bone plasmacytoma is a localized neoplasm in the bone consisting of abnormal plasma cells. We herein report an unusual presentation of solitary bone
plasmacytoma in the mandible. A 57-year-old woman with the lump at the right jaw, which was increased gradually for 13 years. The diagnosis build based on clinical,
radiological, and histopathological findings. She underwent radiotherapy before surgery using a 50 Gy of irradiation for 25 times results in a partial response. A
hemimandibulectomy proceeded, followed by immediate reconstruction using a free vascularized fibular flap. Complete resection may eliminate monoclonal proteins in
serum and reduce disease progression into multiple myeloma. The patient remains to follow up regular visits to the oncology surgery clinic in RSCM, with no recurrence
of disease in six months postoperative.
Keywords: plasmacytoma, mandible, irradiation, mandibular osteotomy

Introduction
Plasmacytoma is an abnormal growth of β cells of lymphoid plasma
cells. It found in two forms: solitary plasmacytoma and multiple
myeloma, according to The International Myeloma Working Group
(IMWG) in 2003. The first mention form of local abnormality from
plasma cell neoplasms, whereas the second one referred to a systemic
form. Solitary plasmacytoma divided into two, namely solitary bone
plasmacytoma and solitary extramedullary plasmacytoma. Solitary
bone plasmacytoma is located in the bone, while the solitary
extramedullary plasmacytoma located in the soft tissue. Solitary bone
plasmacytoma is an infrequent disorder, representing 5-10% of all
plasma cell abnormalities.1,4,11,12, 30 Solitary bone plasmacytoma in the
mandible bone was the rarest case; this case is known to be the most
common in vertebral bone by 42-61%, pelvic bone by 15%, rib by 12%,
lower extremity bone by 12%, upper extremity bone by 10%.4 Solitary
bone plasmacytoma of the mandible reported only in 4.4% of all cases
of solitary bone plasmacytoma. If not appropriately managed, solitary
bone plasmacytoma may develop into multiple myeloma, which has a
poor prognosis with a survival rate of less than two years.2 A combined
treatment modality, which includes radiotherapy and resection, is known
to be effective controlling local tumors and suppressing multiple
myeloma's progression rate. We herein report a case of solitary bone
plasmacytoma in mandible which got combined treatment of resection
and radiotherapy.3,4
Case Report
A 57-year-old woman lives in Flores; East Nusa Tenggara presented
with swelling at lower right mandible, which progressed slowly for 13

years, from the marble-sized lump to tennis-ball-sized swelling. No pain
nor paresthesia, but difficulty in chewing and mouth opening caused by
the swelling. No other complaints on visual components, hearing, and
smell, nor weight reduction.

Figure 1. Clinical presentation of solitary bone plasmacytoma in the
mandible

The extraoral examination showed the lump of 9 cm x 7 cm x 8 cm
sized, uneven surface, no different color around the skin, nor ulcer
around the lump, well-defined, hard in the consistency, immobilized, no
pain on palpation, similar temperature to the surrounding area. No
lymph node enlargement identified. The intraoral examination showing
partial tumor lump inside the oral cavity with intact mucosa was intact.
No ulcer found.
An incisional biopsy carried out with the intraoral approach. The
specimen includes the bony mandible and soft tissue as well – the
pathology indicated plasmacytoma. The specimen showing abnormal
plasma cell proliferation with round-oval shape, pleomorphic, and
grainy-chromatin nucleus scattered diffusely distributed—the
surrounding soft tissue-restricted tumor cell growth.
25
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Laboratory findings were in normal range with Hemoglobin content of
11.2 g/dL, serum ureum of 16 mg/dL, serum creatinin of 0.6 mg/dL,
serum calcium of 9.1 mEq/L. Bence Jones protein in 24-hour urinalysis
negative. From blood electrophoresis test there was increased beta-2 of
globulin fraction with monoclonal image.

After three months follow up, the patient remains regular visits to the
oncology surgery clinic in RSCM. Blood specimens showed no
progressivity to multiple myeloma. The bone survey showed no
abnormalities either.

Three dimensions of facial bone CT-scan proceeded preoperatively. The
scan is showing a solid mass from the mandible showing a lytic lesion
measuring 9.9 cm x 7 cm x 8.8 cm. A destroyed right condyle was
identified, while as ramus, angular, and corpus extended into the soft
tissue, including the mandible's muscular system. There was no lymph
nodes enlargement identified in CT assessment.

Figure 4. Clinical presentation in two months after
hemimandibulectomy and reconstruction using free vascularized
fibular flap.

Figure 2. The 3D facial CT Scan showing extensive destruction of the
hemimandible.

The bone survey was normal; there were no other abnormalities on other
bones. Bone marrow puncture showed no abnormal growth of the
plasma cell. The Immunohistochemistry (IHC) examination sowing
positive Lamda, negative Kappa, and positive CD38. The immunoserology tests from blood specimens showing positive gammopathy
monoclonal IgG kappa, free light chain kappa of 150 mg/L, free chain
lambda of 22.8 mg/L, and kappa/lambda ratio of 6.58.
The intervention to this case consists of the radiotherapy, tumor resection
post-radiotherapy right subtotal mandibulectomy. The treatment
initiated with radiotherapy with 50 Gy doses of radiation for 25 times;
irradiation was given was 2 Gy each. To this irradiation, a partial
response is shown. Right subtotal mandibulectomy proceeded following
irradiation. The mandibular defect reconstructed using a free
vascularized fibular flap.

Figure 3. A subtotal hemimandibulectomy proceeded in removing the
tumor completely.

Figure 5. Intraoral presentation in two months after
hemimandibulectomy and reconstruction using free vascularized
fibular flap.

Discussion
Solitary bone plasmacytoma of the mandible bone reported in 4.4 % of
the overall cases.1,4,11,12,32 A multimodality of test required for the
diagnosis. A complete blood count, renal function, blood calcium levels.
The specific test required is the immunoelectrophoresis-serum test,
quantitative examination of immunoglobulin, bone marrow puncture,
urine Bence Jones protein, and serum lactate dehydrogenase, and β2
immunoglobulin. The other essential investigations, including bone
scans and such as CT Scans, MRI, or PET Scans.5,16 Diagnostic criteria
of IMWG in 2018 are: 1) There are one lytic bone lesions associated
with monoclonal plasma cell infiltration in the radiology with or without
extension into the soft tissue, and plasma cell neoplasms confirmed
results of the histopathologic examination. 2) Clinical and radiological
found only a single lesion of bone examination survey. 3) There is no
description of plasma cell neoplasms in the bone marrow examination.
There is a picture of plasma cell neoplasm in bone marrow examination
with a percentage of less than 10%. 4) There is no damage to other
organs. 5) There are no systemic symptoms such as anemia,
hypercalcemia, and impaired renal function. 6) There is no monoclonal
26
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protein in the urine or serum or monoclonal protein found in urine and
serum with a quantity of less than 2.0 g/L.
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The mandible is an unusual site for this tumor to grow. Should it grows
in the mandible, the resection for local tumor control will be more
straightforward. Hemimandibulectomy is done with consideration to
achieve complete resection of the tumor according to the oncology's
rules, and it shows good aesthetics and function for postsurgery.
Complete resection of plasmacytoma tumor may eliminate monoclonal
proteins in serum and can reduce the progression of the disease into
multiple myeloma.9
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Solitary bone plasmacytoma is a radiosensitive tumor. The
recommended dose of radiotherapy for the management of solitary bone
plasmacytoma is 40 Gy, which is given 20 times if the tumor size is less
than 5 cm, and a minimum of 50 Gy, which is given 25 times if the tumor
size is more than 5 cm. The radiation margin is at least 2 cm from the
tumor boundary. Given this therapy, it is known that the local recurrence
rate is less than 10%, and the rate of progression to multiple myeloma in
10 years decreases to 30-50%.6,9,18,19,20
The tumor response to radiotherapy may found in vary. In common,
giving a radiation response of 93% with 62% complete response and
31% partial response.14 It found that various factors influencing the
success rate of radiotherapy and increasing the rate of progression of the
disease to multiple myeloma, namely: 1) Patients’ age over 60 years 2)
Tumor size more than 5 cm. 3) Monoclonal proteins in serum and urine
after radiation. 4) β2 microglobulin of more than 3.5 mg/L in serum after
radiation. 5) Location of bone lesions in the vertebral bones. 6) Plasma
cell growth in pre-radiation bone marrow examination.3,4,5,6,9,14,21
Study of Bataline and Sony enrolling 114 solitary bone plasmacytoma
cases, which stated that the patients who underwent surgery and
radiotherapy had the lowest incidence of multiple myeloma in the future
compared with patients who received radiotherapy or surgery alone. A
study conducted by the Cancer Center of Sun Yat-Sen University of
Korea also supported this statement.7,8,9 The comparison of local controls
of each group was: 5-year local control of patients who received
radiotherapy alone was 75%, 5-year local control of patients who
received surgery only was 71.4%. In contrast, in solitary bone
plasmacytoma patients receiving radiotherapy combined with surgery,
the highest five-year local control was 84.6%.17
Irradiation, which is initially the primary management, can be a function
of postoperative adjuvant therapy to produce higher local and control
numbers, and reduce the progression of the disease to multiple myeloma
in the future. Therefore, if a case of solitary bone plasmacytoma is found
in the mandible, surgery should be carried out before radiation. The
tumor in the mandible can be excised completely and may eliminate
monoclonal proteins in serum, reduce the progression of the disease into
multiple myeloma.
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